PolyPeptide Shares Surge Amid Takeover Interest From EQT, KKR
PolyPeptide Group AG shares hit the highest level in more than three years, after people with knowledge of the matter said the Swiss contract drugmaker is attracting private equity takeover...
By Dinesh Nair, Allegra Catelli, Manuel Baigorri · Bloomberg
PolyPeptide Group AG shares hit the highest level in more than three years, after people with knowledge of the matter said the Swiss contract drugmaker is attracting private equity takeover interest.